Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Free Cash Flow Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn -
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 19.08%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn 22.20%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.20%
Mar 31, 2026 4.94%
Dec 31, 2025 -23.04%
Jun 30, 2025 39.16%
Mar 31, 2025 6.27%
Dec 31, 2024 27.58%
Sep 30, 2024 24.29%
Jun 30, 2024 43.23%
Mar 31, 2024 10.46%
Dec 31, 2023 54.47%
Jun 30, 2023 17.55%
Mar 31, 2023 118.28%
Dec 31, 2022 109.06%
Jun 30, 2022 78.03%
Mar 31, 2022 163.05%
Dec 31, 2021 -11.82%
Sep 30, 2021 40.67%
Jun 30, 2021 51.70%
Mar 31, 2021 209.01%
Dec 31, 2020 13.60%